We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Takeda is eager to close its Shire deal and begin taking the specialty pharma under its wing, but for now the company is touting a few strengths in its own business. What's it bragging about? Stronger-than-expected...